Pascal Touchon - 16 May 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
President and CEO, Director
Signature
/s/ John Chao, Attorney-in-Fact for Pascal Touchon
Issuer symbol
ATRA
Transactions as of
16 May 2024
Net transactions value
-$50,289
Form type
4
Filing time
20 May 2024, 20:34:45 UTC
Previous filing
06 Mar 2024
Next filing
14 Aug 2024
SEC
View on sec.gov

Quoteable Key Fact

"Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 20 May 2024."

Quick Takeaways

  • This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 20 May 2024, 20:34.

What Changed

  • Previous filing in this sequence was filed on 06 Mar 2024.
  • Current net transaction value: -$50,289.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $50,289 -81,506 -4.3% $0.6170 1,829,146 16 May 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2024 and May 17, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.